NOMOGRAM FOR ESTIMATING CREATININE CLEARANCE

被引：45
作者：
BJORNSSON, TD
COCCHETTO, DM
MCGOWAN, FX
VERGHESE, CP
SEDOR, F
机构：
[1] DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA
[2] DUKE UNIV, MED CTR, DEPT CLIN CHEM, DURHAM, NC 27710 USA
来源：
CLINICAL PHARMACOKINETICS | 1983年 / 8卷 / 04期
关键词：
D O I：
10.2165/00003088-198308040-00007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：365 / 369
页数：5
相关论文
共 29 条
[1]   USE OF SERUM CREATININE CONCENTRATIONS TO DETERMINE RENAL-FUNCTION [J].
BJORNSSON, TD .
CLINICAL PHARMACOKINETICS, 1979, 4 (03) :200-222
[2]   CREATINE AND MUSCULAR DYSTROPHY - RELATIONSHIP OF CREATINE-CREATININE METABOLISM TO DIET AND DRUGS [J].
BOURDAKOS, NG ;
WOLF, S .
ARCHIVES OF NEUROLOGY, 1962, 6 (06) :439-&
[3]   NOMOGRAMS FOR DRUG-USE IN RENAL-DISEASE [J].
CHENNAVASIN, P ;
BRATER, DC .
CLINICAL PHARMACOKINETICS, 1981, 6 (03) :193-214
[4]  
COCCHETTO DM, 1983, THERAPEUTIC DRUG MON
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]  
DETTLI L, 1971, ACTA PHARMACOL TOX, V29, P211
[7]  
DETTLI L, 1977, PROG PHARMACOL, V1, P1
[8]   A CLINICAL APPRAISAL OF PLASMA CONCENTRATION AND ENDOGENOUS CLEARANCE OF CREATININE [J].
DOOLAN, PD ;
ALPEN, EL ;
THEIL, GB .
AMERICAN JOURNAL OF MEDICINE, 1962, 32 (01) :65-&
[9]  
EFFERSOE P, 1957, ACTA MED SCAND, V156, P429
[10]  
GIBALDI M, 1975, PHARMACOKINETICS, P253
123